The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma.
Leek, R., Lewis, C. E., Whitehouse, R. M., Greenall, M. J., Clarke, J., & Harris, A. L. (1996) · PubMed · Cited by 1,187
Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in Mice
Bergers, G., Javaherian, K., Lo, K.-M., Folkman, J., & Hanahan, D. (1999) · Science · doi:10.1126/science.284.5415.808 · Cited by 988
The importance of dose intensity in chemotherapy of metastatic breast cancer.
Hryniuk, W., & Bush, H. (1984) · Journal of Clinical Oncology · doi:10.1200/jco.1984.2.11.1281 · Cited by 885
Vascular permeability factor (VPF, VEGF) in tumor biology
Senger, D. R., Van De Water, L., Brown, L. F., Nagy, J. A., Yeo, K.-T., Yeo, T.-K., Berse, B., Jackman, R. W., Dvorak, A. M., & Dvorak, H. F. (1993) · Cancer and Metastasis Reviews · doi:10.1007/bf00665960 · Cited by 840
Hortobagyi, G. N. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810013391407 · Cited by 781
Dose-Response Effect of Adjuvant Chemotherapy in Breast Cancer
Bonadonna, G., & Valagussa, P. (1981) · New England Journal of Medicine · doi:10.1056/nejm198101013040103 · Cited by 774
Levine, M. N., Bramwell, V. H., Pritchard, K. I., Norris, B. D., Shepherd, L. E., Abu-Zahra, H., Findlay, B., Warr, D., Bowman, D., Myles, J., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2651 · Cited by 617
Klauber, N., Parangi, S., Flynn, E. A., Hamel, E., & D’Amato, R. J. (1997) · PubMed · Cited by 524
Risk of Leukemia after Chemotherapy and Radiation Treatment for Breast Cancer
Curtis, R. E., Boice, J. D., Stovall, M., Bernstein, L., Greenberg, R. S., Flannery, J. T., Schwartz, A. G., Weyer, P., Moloney, W. C., & Hoover, R. N. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206253262605 · Cited by 446
Platelet: transporter of vascular endothelial growth factor.
Verheul, H. M. W., Hoekman, K., Bakker, S., Eekman, C., Folman, C. C., Broxterman, H. J., & Pinedo, H. M. (1997) · PubMed · Cited by 428
The role of vascular endothelial growth factor in pathological angiogenesis
Ferrara, N. (1995) · Breast Cancer Research and Treatment · doi:10.1007/bf00666035 · Cited by 414
Toi, M., Inada, K., Suzuki, H., & Tominaga, T. (1995) · Breast Cancer Research and Treatment · doi:10.1007/bf00666040 · Cited by 362
Involvement of platelets in tumour angiogenesis?
Pinedo, H., Verheul, H., D'Amato, R., & Folkman, J. (1998) · The Lancet · doi:10.1016/s0140-6736(98)05095-8 · Cited by 358
Saleh, M., Stacker, S. A., & Wilks, A. F. (1996) · PubMed · Cited by 354
Adams, J., Carder, P. J., Downey, S. E., Forbes, M. A., MacLennan, K. A., Allgar, V. L., Kaufman, S., Hallam, S., Bicknell, R., Walker, J. J., et al. (2000) · PubMed · Cited by 339
Oral chemotherapy: rationale and future directions.
DeMario, M. D., & Ratain, M. J. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.7.2557 · Cited by 293
Linderholm, B., Grankvist, K., Wilking, N., Johansson, M., Tavelin, B., & Henriksson, R. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.7.1423 · Cited by 254
Salvén, P., Orpana, A., & Joensuu, H. (1999) · PubMed · Cited by 252
New perspectives in clinical oncology from angiogenesis research
Folkman, J. (1996) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00423-6 · Cited by 250
Hirata, S., Matsubara, T., Saura, R., Hirohata, K., & Tateishi, H. (1989) · Arthritis & Rheumatism · doi:10.1002/anr.1780320903 · Cited by 201
Serum vascular endothelial growth factor is often elevated in disseminated cancer.
Salvén, P., Mänpää, H., Orpana, A., Alitalo, K. K., & Joensuu, H. (1997) · PubMed · Cited by 188
Clinical significance of plasma vascular endothelial growth factor in gastrointestinal cancer
Hyodo, I., Doi, T., Endo, H., Hosokawa, Y., Nishikawa, Y., Tanimizu, M., Jinno, K., & Kotani, Y. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00282-2 · Cited by 175
Salgado, R., Vermeulen, P. B., Benoy, I., Weytjens, R., Huget, P., Marck, E. V., & Dirix, L. Y. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690437 · Cited by 165
Clinical Implications of Tumor-Cell Heterogeneity
Epstein, F. H., & Schnipper, L. E. (1986) · New England Journal of Medicine · doi:10.1056/nejm198605293142206 · Cited by 128
The influence of angiogenesis research on management of patients with breast cancer
Folkman, J. (1995) · Breast Cancer Research and Treatment · doi:10.1007/bf00666033 · Cited by 73
Agrawal, R., Conway, G. S., Sladkevicius, P., Payne, N. N., Bekir, J. S., Campbell, S. C., Tan, S. L., & Jacobs, H. S. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00618.x · Cited by 66
Heer, K., Kumar, H., Speirs, V., Greenman, J., Drew, P. J., Fox, J. N., Carleton, P. J., Monson, J. Q., & Kerin, M. J. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.655 · Cited by 62
Harris, A. L., Zhang, H., Moghaddam, A., Fox, S., Scott, P. A. E., Pattison, A. J., Gatter, K. C., Stratford, I. J., & Bicknell, R. (1996) · Breast Cancer Research and Treatment · doi:10.1007/bf01803788 · Cited by 54
Weidner, N. (1996) · Cancer treatment and research · doi:10.1007/978-1-4613-1259-8_14 · Cited by 50
The role of angiogenic growth factors in breast cancer progression
Kern, F. G., & Lippman, M. E. (1996) · Cancer and Metastasis Reviews · doi:10.1007/bf00437474 · Cited by 20
Dickson, R. B., Johnson, M. D., Maemura, M., & Low, J. A. (1996) · Breast Cancer Research and Treatment · doi:10.1007/bf01803790 · Cited by 14
Chemotherapy for Metastatic Disease
Sejima, T., Morizane, S., Yao, A., Isoyama, T., & Takenak, A. (2012) · InTech eBooks · doi:10.5772/27447 · Cited by 11
Cited by
The anti-angiogenic basis of metronomic chemotherapy
Kerbel, R. S., & Kamen, B. A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1369 · Cited by 1,397
Klement, G., Baruchel, S., Rak, J., Man, S., Clark, K., Hicklin, D. J., Bohlen, P., & Kerbel, R. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8829 · Cited by 1,168
Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice
Hanahan, D., Bergers, G., & Bergsland, E. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9872 · Cited by 865
Metronomic chemotherapy: new rationale for new directions
Pasquier, E., Kavallaris, M., & André, N. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.82 · Cited by 659
Folprecht, G., Grothey, A., Alberts, S., Raab, H.-R., & Köhne, C.-H. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi246 · Cited by 632
Metadata
- Authors
- Colleoni, M., Rocca, A., Sandri, M. T., Zorzino, L., Masci, G., Nolè, F., Peruzzotti, G., Robertson, C., Orlando, L., Cinieri, S., de Braud, F., Viale, G., & Goldhirsch, A.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2002-01
- Volume
- 13
- Issue
- 1
- Pages
- 73-80
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2104316189
- Cited by
- 496
- References
- 32
- FWCI
- 9.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.